Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals.
about
Un-sweetening the Heart: Possible pleiotropic effects of SGLT2 inhibitors on cardio and cerebrovascular alterations in resistant hypertensive subjects.Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction.Therapeutic potential of tofogliflozin on nephrotic syndrome secondary to diabetic nephropathy
P2860
Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@en
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@nl
type
label
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@en
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@nl
prefLabel
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@en
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@nl
P2093
P2860
P356
P1476
Tofogliflozin, a selective inh ...... e and type 2 diabetic animals.
@en
P2093
Sho-Ichi Yamagishi
Takanori Matsui
Yuji Ishibashi
P2860
P304
P356
10.1177/1479164116657304
P407
P577
2016-07-12T00:00:00Z